Seeking AlphaCodex · 实盘不做把握 8/10
北京时间·🕒 发布 08-03 23:10:53时区推断·⟳ 抓取 08-03 23:11:01·⚡ 决策 08-04 11:15:48 +12h04m·84.3 天前
Harmony Biosciences将于8月4日盘前公布Q2业绩
当前仅为业绩日历预告，市场一致预期为EPS 1.15美元、收入2.5327亿美元。
📄 原文Seeking Alpha↗ 原文
Harmony Biosciences Holdings, Inc. Q2 2026 Earnings Preview
- Harmony Biosciences Holdings, Inc. (HRMY) is scheduled to announce Q2 earnings results on Tuesday, August 4th, before…
不做 Harmony Biosciences（HRMY.US）
仅为Q2业绩发布时间和consensus预告，尚无实际超预期或低于预期信息，需等财报结果新信号。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-08-03 · 扩散 medium · price-in 风险 high ↗
关键理由
- 当前仅为业绩日历预告，市场一致预期为EPS 1.15美元、收入2.5327亿美元。
- 尚未披露实际业绩、指引或超预期幅度，无法判断方向性交易。
主要风险
- 盘前真实业绩公布后可能出现大幅波动，但需由新信号按实际结果重判。
原文全文
展开原文 · 512 字
- Harmony Biosciences Holdings, Inc. (HRMY) is scheduled to announce Q2 earnings results on Tuesday, August 4th, before market open.
- The consensus EPS Estimate is $1.15 (+25.0% Y/Y) and the consensus Revenue Estimate is $253.27M (+26.3% Y/Y).
- Over the last 2 years, HRMY has beaten EPS estimates 63% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward. Revenue estimates have seen 4 upward revisions and 3 downward.
- The consensus EPS Estimate is $1.15 (+25.0% Y/Y) and the consensus Revenue Estimate is $253.27M (+26.3% Y/Y).
- Over the last 2 years, HRMY has beaten EPS estimates 63% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward. Revenue estimates have seen 4 upward revisions and 3 downward.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。